FR3030280B1 - Composition filmogene et son utilisation pour le traitement des affections bucco-linguales - Google Patents

Composition filmogene et son utilisation pour le traitement des affections bucco-linguales Download PDF

Info

Publication number
FR3030280B1
FR3030280B1 FR1402944A FR1402944A FR3030280B1 FR 3030280 B1 FR3030280 B1 FR 3030280B1 FR 1402944 A FR1402944 A FR 1402944A FR 1402944 A FR1402944 A FR 1402944A FR 3030280 B1 FR3030280 B1 FR 3030280B1
Authority
FR
France
Prior art keywords
filmogene
bucco
lingual
diseases
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1402944A
Other languages
English (en)
Other versions
FR3030280A1 (fr
Inventor
Sophie Desforges
Claire Bouvier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Urgo SAS
Original Assignee
Laboratoires Urgo SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Urgo SAS filed Critical Laboratoires Urgo SAS
Priority to FR1402944A priority Critical patent/FR3030280B1/fr
Priority to PCT/FR2015/053575 priority patent/WO2016097623A1/fr
Priority to KR1020177016363A priority patent/KR20170117369A/ko
Publication of FR3030280A1 publication Critical patent/FR3030280A1/fr
Application granted granted Critical
Publication of FR3030280B1 publication Critical patent/FR3030280B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR1402944A 2014-12-19 2014-12-19 Composition filmogene et son utilisation pour le traitement des affections bucco-linguales Active FR3030280B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR1402944A FR3030280B1 (fr) 2014-12-19 2014-12-19 Composition filmogene et son utilisation pour le traitement des affections bucco-linguales
PCT/FR2015/053575 WO2016097623A1 (fr) 2014-12-19 2015-12-17 Composition filmogène et son utilisation pour le traitement des affections bucco-linguales
KR1020177016363A KR20170117369A (ko) 2014-12-19 2015-12-17 협설측 질환 치료용 피막 형성 조성물 및 이의 용도

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1402944A FR3030280B1 (fr) 2014-12-19 2014-12-19 Composition filmogene et son utilisation pour le traitement des affections bucco-linguales
FR1402944 2014-12-19

Publications (2)

Publication Number Publication Date
FR3030280A1 FR3030280A1 (fr) 2016-06-24
FR3030280B1 true FR3030280B1 (fr) 2018-01-19

Family

ID=52785137

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1402944A Active FR3030280B1 (fr) 2014-12-19 2014-12-19 Composition filmogene et son utilisation pour le traitement des affections bucco-linguales

Country Status (3)

Country Link
KR (1) KR20170117369A (fr)
FR (1) FR3030280B1 (fr)
WO (1) WO2016097623A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3064488B1 (fr) * 2017-03-31 2021-01-01 Urgo Rech Innovation Et Developpement Composition contenant un derive de cellulose, un plastifiant, un solvant volatil et un actif, ses utilisations comme pansement

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5081158A (en) * 1988-05-02 1992-01-14 Zila Pharmaceuticals, Inc. Compositions and in situ methods for forming films on body tissue
US5885611A (en) * 1997-06-04 1999-03-23 Colgate-Palmolive Company Bandage-forming gel for oral mucosa

Also Published As

Publication number Publication date
WO2016097623A1 (fr) 2016-06-23
FR3030280A1 (fr) 2016-06-24
KR20170117369A (ko) 2017-10-23

Similar Documents

Publication Publication Date Title
MA45481A (fr) Utilisation d'exosomes pour le traitement de maladies
MA45192A (fr) Traitement d'association
IL255509B (en) Compounds as modulators of ccr2, pharmaceutical preparations containing them and their use in the treatment of diseases
MA43135A (fr) Compositions et méthodes pour le du traitement du cancer
MA42420A (fr) Vaccins pour le traitement et la prévention du cancer
MA41028A (fr) Méthodes et formulations pour le traitement de pathologies oculaires vasculaires
EA201691582A1 (ru) Новые фармацевтические препараты
MA39960A (fr) Composés imidazo[4,5c]quinoline-2-one et leur utilisation dans le traitement du cancer
HK1252813A1 (zh) 用於治療社交障礙和藥物使用障礙的治療性化合物和組合物
GB201411241D0 (en) Novel dihydropyridoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders
MA43361A (fr) Composition pour le soin et la protection de cultures
DK3151851T3 (da) Ornithodoros-moubata-komplement-inhibitor til anvendelse i behandlingen af komplement-medierede sygdomme hos patienter med c5-polymorfisme
MA53568A (fr) Médicaments pour le traitement de maladies ophtalmiques
GB201404403D0 (en) Compositions and methods relating to the treatment of diseases
FR3022139B1 (fr) Nouvelles compositions pour le traitement des rougeurs cutanees et de la rosacee
FR3020951B1 (fr) Association d'un tetrapeptide et d'un glyceryl ester pour le traitement de l'alopecie androgenique.
MA41629A (fr) Compositions et méthodes d'utilisation de l'hormone anti-müllérienne pour le traitement de l'infertilité
GB201518456D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory, autoimmune and/or proliferative diseases
DE112015002229A5 (de) Formulierungen zur Behandlung von Hyperthyreose
FR3015285B1 (fr) Formulation pour le traitement des cheveux
MA40687A (fr) Méthodes et compositions de traitement de malformation vasculaire
FR3044227B1 (fr) Derives aminophosphiniques pour la prevention et le traitement des douleurs oculaires
EP3156054A4 (fr) Médicament pour la prévention et/ou le traitement de maladies induites par le stress
DK3096775T3 (da) SOCS-mimetika til behandling af sygdomme
MA41782A (fr) Traitement de patients atteints de diabète de type 2

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

EXTE Extension to a french territory

Extension state: PF

PLSC Publication of the preliminary search report

Effective date: 20160624

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10